07 Jan 2001

Dinoven 0.445% - España

Updated: 07 Jan 2001

Dinoven 0.445% pomada 30 g

Procesos varicosos, tromboflebitis superficial. Hematomas, tumefacciones.

Dinoven 0.445% Description, Presentation and Dosage

Dinoven 0.445% Description

Dinoven 0.445% Drug Class Description

Antivaricosos topicos

Dinoven 0.445% Drug Description


Dinoven 0.445% Presentation

Dinoven 0.445% Presentation

Tópica: Adultos: 5-10 cm 2-4 veces al día. Niños: 2.5-5 cm 2-4 veces al día. No aplicar el gel en membranas mucosa o heridas abierta debido a su contenido en alcohol.

Dinoven 0.445% Manufacturer


Related Learning Zones

Obesity CME series

Obesity CME series

This European Obesity Initiative CME series contains three online modules, which are ideal for healthcare professionals looking to widen their understanding of obesity as a serious medical illness. Each module is EACCME-accredited and free to complete. Successful completion of the series will earn participants a combined total of 5 European CME credits (ECMECs).

Type 2 Diabetes

Type 2 Diabetes

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Dinoven 0.445% Dosage

Dinoven 0.445% Precautions, Reactions and Contraindications

Dinoven 0.445% Special Precautions

Dinoven 0.445% Adverse Reactions

Dinoven 0.445% Adverse Reactions

Los efectos adversos de este medicamento son, en general, infrecuentes leves y transitorios. Los efectos adversos más característicos son:. -Raramente (<1%): alteraciones alérgicas: urticaria y eritema.

Related Drugs - Cardiología

Back to top